We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTY
976
DELISTED
Party City Holdco Inc.
PRTY
| $974K | 0.01% |
+158,349
| New | +$615K |
|
977
Atara Biotherapeutics
ATRA
$75.8M
| $967K | 0.01% |
+1,970
| New | +$909K |
|
978
Takeda Pharmaceutical
TAK
$55.6B
| $962K | 0.01% |
52,861
-73,695
| -58% | -$1.29M |
|
979
John Wiley & Sons Class A
WLY
$2.58B
| $962K | 0.01% |
21,060
-23,015
| -52% | -$834K |
|
|
VG
980
DELISTED
Vonage Holdings Corporation
VG
| $962K | 0.01% |
74,744
+50,928
| +214% | +$620K |
|
|
HR
981
DELISTED
Healthcare Realty Trust Incorporated
HR
| $958K | 0.01% |
+32,356
| New | +$973K |
|
982
Lumentum
LITE
$81.1B
| $948K | 0.01% |
+9,997
| New | +$862K |
|
|
WPX
983
DELISTED
WPX Energy, Inc.
WPX
| $940K | 0.01% |
+115,381
| New | +$733K |
|
|
GWB
984
DELISTED
Great Western Bancorp, Inc.
GWB
| $939K | 0.01% |
44,950
-82,238
| -65% | -$1.35M |
|
985
Ascendis Pharma A/S
ASND
$16.2B
| $937K | 0.01% |
5,618
-1,439
| -20% | -$238K |
|
986
Coca-Cola Femsa
KOF
$23.2B
| $931K | 0.01% |
20,198
-2,323
| -10% | -$101K |
|
987
Semtech
SMTC
$12.9B
| $931K | 0.01% |
+12,919
| New | +$825K |
|
988
Qualys
QLYS
$6.57B
| $927K | 0.01% |
+7,607
| New | +$753K |
|
|
CBB
989
DELISTED
Cincinnati Bell Inc.
CBB
| $925K | 0.01% |
60,523
-80,680
| -57% | -$1.23M |
|
990
Honeywell
HON
$74B
| $921K | 0.01% |
+4,592
| New | +$834K |
|
991
Pebblebrook Hotel Trust
PEB
$2.04B
| $916K | 0.01% |
+48,726
| New | +$788K |
|
992
Protolabs
PRLB
$2.19B
| $916K | 0.01% |
+5,971
| New | +$842K |
|
|
UCTT
993
Ultra Clean Holdings
UCTT
$4.25B
| $916K | 0.01% |
+29,409
| New | +$821K |
|
|
CRON
994
Cronos Group
CRON
$1.18B
| $914K | 0.01% |
+131,706
| New | +$907K |
|
995
Quince Therapeutics
QNCX
$33.9M
| $910K | 0.01% |
+164
| New | +$1.45M |
|
996
Harley-Davidson
HOG
$2.87B
| $906K | 0.01% |
+24,688
| New | +$847K |
|
|
PRA
997
DELISTED
ProAssurance
PRA
| $892K | 0.01% |
50,122
-40,241
| -45% | -$656K |
|
|
NP
998
DELISTED
Neenah, Inc. Common Stock
NP
| $891K | 0.01% |
16,100
-12,460
| -44% | -$572K |
|
999
Steris
STE
$22.9B
| $890K | 0.01% |
4,696
-5,384
| -53% | -$1M |
|
1000
Broadridge
BR
$19.2B
| $887K | 0.01% |
5,790
-4,791
| -45% | -$695K |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.